Funded Grants

Late-onset Alzheimer’s (late-AD) is a complex neurodegenerative condition with abnormalities in toxic protein accumulation, vascularization, inflammation, neuronal activity and cerebral atrophy.

Canada recently became the first G7 nation to legalize Cannabis for medicinal and recreational use.

The human experience is marked by constant learning.

In the past decade, rapid development of software has allowed detection of a wide variety of genetic risk factors in brain disorders.

Ependymal cells are a largely understudied barrier cell type in the brain that provide a wall between brain tissue and brain fluid (cerebral spinal fluid, CSF), playing an important role in regulating fluid balance.

Brain disorders and disease represent an immense societal burden and the leading cost to the Canadian health care system.

Depression will affect 1 out of 5 individuals in their lifetime.

The common end stage pathology of neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS) is neuronal death.

Spinal cord injury (SCI) is a devastating medical condition that forever changes the trajectory of life.

Metabolic syndrome is a group of risk factors (obesity, hypertension, high fasting blood sugar, and high levels of triglycerides) that increase the risk of type 2 diabetes and cardiovascular diseases.